Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease
Abstract Bile acid (BA) and its receptor FXR play crucial roles in metabolism, and dysregulated BA synthesis regulated by hepatic and bacterial enzymes causes metabolic dysfunction-associated steatohepatitis (MASH) and hepatocellular carcinoma (HCC). Moreover, because ~ 75% of hepatic blood is from...
Saved in:
| Main Authors: | Guiyan Yang, Yu-Jui Yvonne Wan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Biomarker Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40364-024-00694-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbiome-derived bile acids as endogenous regenerative mediators in liver repair
by: Surya Nath Pandey, et al.
Published: (2025-12-01) -
Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease
by: Ting Zhou, et al.
Published: (2025-06-01) -
Dietary bile acid supplementation improves the intestinal health and growth performance of piglets partially through the FXR/AQPs pathway
by: Beibei Zhang, et al.
Published: (2025-05-01) -
Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01) -
Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
by: Rachmad Anres Dongoran, et al.
Published: (2023-01-01)